WELCURE DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/10/2022 ,inter alia, to consider and approve the Un-Audited Financial Results of the Company for the Quarter and half year ended 30th September, 2022. As per our letter dated 30th September, 2022 and pursuant to the Company''s Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the securities of the Company will be closed for 'Designated Persons'' for trading from Saturday, 01st October, 2022 and the same shall remain closed till 48 hours after announcement of Financial Results for the quarter and half year ended 30th September, 2022 to the stock exchanges. This is for your information and records.